These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27455999)

  • 21. Preventing warfarin-related bleeding.
    Glasheen JJ
    South Med J; 2005 Jan; 98(1):96-103. PubMed ID: 15678642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
    Abraham NS; Singh S; Alexander GC; Heien H; Haas LR; Crown W; Shah ND
    BMJ; 2015 Apr; 350():h1857. PubMed ID: 25910928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombomodulin as a marker for bleeding complications during warfarin treatment.
    Lind M; Boman K; Johansson L; Nilsson TK; Ohlin AK; Birgander LS; Jansson JH
    Arch Intern Med; 2009 Jul; 169(13):1210-5. PubMed ID: 19597070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of hemorrhage among patients with warfarin-associated coagulopathy.
    Garcia DA; Regan S; Crowther M; Hylek EM
    J Am Coll Cardiol; 2006 Feb; 47(4):804-8. PubMed ID: 16487849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Warfarin users, beware of antibiotics. Interactions may increase the risk of internal bleeding.
    Harv Heart Lett; 2012 Jun; 22(10):3. PubMed ID: 22764397
    [No Abstract]   [Full Text] [Related]  

  • 26. Are major bleeding events from falls more likely in patients on warfarin?
    Garvin R; Howard E
    J Fam Pract; 2006 Feb; 55(2):159-60; discussion 159. PubMed ID: 16451785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health records.
    Menzin J; White LA; Friedman M; Nichols C; Menzin J; Hoesche J; Bergman GE; Jones C
    Thromb Haemost; 2012 Apr; 107(4):662-72. PubMed ID: 22318400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
    Di Nisio M; Raskob G; Büller HR; Grosso MA; Zhang G; Winters SM; Cohen A
    Thromb Haemost; 2017 Apr; 117(4):784-793. PubMed ID: 28151543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematology consult: high-sensitivity warfarin genotype.
    Schwer C; Lamana S; Dasanu CA
    Conn Med; 2013; 77(10):581-5. PubMed ID: 24367840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving Warfarin Management Within the Medical Home: A Health-System Approach.
    Rose AE; Robinson EN; Premo JA; Hauschild LJ; Trapskin PJ; McBride AM
    Am J Med; 2017 Mar; 130(3):365.e7-365.e12. PubMed ID: 27984006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of International Society on Thrombosis and Haemostasis major and clinically relevant non-major bleed events from electronic health records: a novel algorithm to enhance data utilisation from real-world sources.
    Hartenstein A; Abdelgawwad K; Kleinjung F; Privitera S; Viethen T; Vaitsiakhovich T
    Int J Popul Data Sci; 2023; 8(1):2144. PubMed ID: 38414540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleeding complications in patients on celecoxib and warfarin.
    Chung L; Chakravarty EF; Kearns P; Wang C; Bush TM
    J Clin Pharm Ther; 2005 Oct; 30(5):471-7. PubMed ID: 16164494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation.
    Boulanger L; Hauch O; Friedman M; Foster T; Dixon D; Wygant G; Menzin J
    Ann Pharmacother; 2006 Jun; 40(6):1024-9. PubMed ID: 16735649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
    Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY
    J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An observational study examining the impact of capecitabine on warfarin antithrombotic activity and bleeding complications.
    Yood MU; Quesenberry CP; Alford SH; Tsai AL; Wells KE; Yood SM; Ackermann Shiff SP
    Curr Med Res Opin; 2006 Feb; 22(2):307-14. PubMed ID: 16466602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.
    Bahit MC; Lopes RD; Wojdyla DM; Held C; Hanna M; Vinereanu D; Hylek EM; Verheugt F; Goto S; Alexander JH; Wallentin L; Granger CB
    Heart; 2017 Apr; 103(8):623-628. PubMed ID: 27798052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
    Healey JS; Eikelboom J; Douketis J; Wallentin L; Oldgren J; Yang S; Themeles E; Heidbuchel H; Avezum A; Reilly P; Connolly SJ; Yusuf S; Ezekowitz M;
    Circulation; 2012 Jul; 126(3):343-8. PubMed ID: 22700854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial.
    Piccini JP; Garg J; Patel MR; Lokhnygina Y; Goodman SG; Becker RC; Berkowitz SD; Breithardt G; Hacke W; Halperin JL; Hankey GJ; Nessel CC; Mahaffey KW; Singer DE; Califf RM; Fox KA;
    Eur Heart J; 2014 Jul; 35(28):1873-80. PubMed ID: 24658769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin.
    Brekelmans MP; Scheres LJ; Bleker SM; Hutten BA; Timmermans A; Büller HR; Middeldorp S
    Thromb Haemost; 2017 Apr; 117(4):809-815. PubMed ID: 28180233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of dabigatran bleeding adverse reaction reports in the FDA adverse event reporting system during the first year of approval.
    McConeghy KW; Bress A; Qato DM; Wing C; Nutescu EA
    Pharmacotherapy; 2014 Jun; 34(6):561-9. PubMed ID: 24644100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.